Advertisement
Journal Home
Search for

Volume 36, Issue 5, Pages 512-521 (May 2005)


View previous. 13 of 28 View next.

Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: An immunohistochemical study for OCT3/4 and TSPY

Anne-Marie F. Kersemaekers, PhDa1, Friedemann Honecker, MDab12, Hans Stoop, BSca, Martine Cools, MDa, Michel Molier, BSca2, Katja Wolffenbuttel, MDc, Carsten Bokemeyer, MDb, Yunmin Li, PhDd, Yun-Fai Chris Lau, PhDd, J. Wolter Oosterhuis, MD, PhDa, Leendert H.J. Looijenga, PhDaCorresponding Author Informationemail address

Received 1 February 2005; accepted 15 February 2005.

Summary 

Carcinoma in situ (CIS) is the precursor of malignant testicular germ cell tumors (GCTs) of adolescents and young adults, being the neoplastic counterpart of primordial germ cells/gonocytes. Carcinoma in situ cells will develop into invasive seminoma/nonseminoma. Gonadoblastoma (GB) is the precursor of invasive GCTs in dysgenetic gonads, predominantly dysgerminoma (DG). In this process, part of the Y chromosome (GBY region) is involved, for which TSPY is a candidate gene. A detailed immunohistochemical survey was performed for the known diagnostic markers, germ cell/placental alkaline phosphatase (PLAP), c-KIT, and OCT3/4, as well as testis-specific protein on the Y chromosome (TSPY) on a series of GBs, and adjacent invasive DGs. All 5 patients were XY individuals (4 females and 1 male). In contrast to c-KIT, PLAP was positive in all cases. The immature germ cells of GBs were positive for OCT3/4, whereas the mature germ cells were negative for this marker, but positive for TSPY. In every GB, a minor population of germ cells positive for both markers could be identified, similar to most CIS cells and early invasive DG. On progression to an invasive tumor, TSPY can be lost, a process that is also detectable in invasive testicular GCTs compared to CIS. These results indicate that GB is a heterogeneous mix of germ cells, in which the OCT3/4-positive cells have the potential to undergo progression to an invasive tumor. These early invasive stages are initially also positive for TSPY (like CIS), supporting a positive selection mechanism. Therefore, OCT3/4 in combination with TSPY is valuable to identify malignant germ cells in dysgenetic gonads. This could allow better prediction of the risk of progression to a GCT. In addition, the data support the model that GB represents the earliest accessible developmental stage of malignant GCTs.

a Department of Pathology, Josephine Nefkens Institute, Daniel den Hoed Cancer Center, Erasmus MC-University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands

b Department of Hematology/Oncology, University of Tübingen, 72076 Tübingen, Germany

c Department of Pediatric Urology, Sophia Children's Hospital, Erasmus MC-University Medical Center Rotterdam, 3015 GJ Rotterdam, The Netherlands

d Division of Cell and Developmental Genetics, Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA

Corresponding Author InformationCorresponding author.

 This study was financially supported by the Dutch Cancer Society, grant number 2002 2682 (AMK, HS, JWO, LHJL), and the Deutsche Krebshilfe, Dr Mildred Scheel Stiftung (F.H.), and the European Society for Pediatric Endocrinology, ESPE sponsored by Novo Nordisk A/S (MC).

1 Both authors contributed equally to the work.

2 Current address: Department of Oncology and Hematology, University Hospital Hamburg Eppendorf, Martinstr. 52, 20246 Hamburg, Germany.

PII: S0046-8177(05)00085-7

doi:10.1016/j.humpath.2005.02.016


View previous. 13 of 28 View next.

Advertisement